Evergreen Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,812
Closed -$365K 1575
2026
Q1
$365K Buy
+5,812
New +$405K 0.01% 990
2023
Q3
Sell
-1,793
Closed -$230K 810
2023
Q2
$230K Buy
1,793
+55
+3% +$6.65K 0.01% 665
2023
Q1
$202K Buy
+1,738
New +$195K 0.01% 655

Other funds holding DXCM

Evergreen Capital Management's DXCM Position: Q2 2026 in Review

Evergreen Capital Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 5,812 shares — an estimated $365K sold.

Evergreen Capital Management first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $365K in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Evergreen Capital Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Evergreen Capital Management sold 5,812 DexCom shares in Q2 2026, an estimated $365K.
  • Evergreen Capital Management first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • Evergreen Capital Management's DexCom position peaked at $365K in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.